IBDEI1CP ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23929,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,23930,0)
 ;;=425.4^^130^1451^17
 ;;^UTILITY(U,$J,358.3,23930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23930,1,3,0)
 ;;=3^Primary Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,23930,1,4,0)
 ;;=4^425.4
 ;;^UTILITY(U,$J,358.3,23930,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,23931,0)
 ;;=428.0^^130^1451^7
 ;;^UTILITY(U,$J,358.3,23931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23931,1,3,0)
 ;;=3^Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,23931,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,23931,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,23932,0)
 ;;=496.^^130^1451^5
 ;;^UTILITY(U,$J,358.3,23932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23932,1,3,0)
 ;;=3^Chr Airway Obstruct Nec
 ;;^UTILITY(U,$J,358.3,23932,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,23932,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,23933,0)
 ;;=491.21^^130^1451^13
 ;;^UTILITY(U,$J,358.3,23933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23933,1,3,0)
 ;;=3^Ob Ch Bronchitis W Exacerb
 ;;^UTILITY(U,$J,358.3,23933,1,4,0)
 ;;=4^491.21
 ;;^UTILITY(U,$J,358.3,23933,2)
 ;;=^269954
 ;;^UTILITY(U,$J,358.3,23934,0)
 ;;=493.20^^130^1451^6
 ;;^UTILITY(U,$J,358.3,23934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23934,1,3,0)
 ;;=3^Chr Obs Asthma W/O Stat Asth/A
 ;;^UTILITY(U,$J,358.3,23934,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,23934,2)
 ;;=^269964
 ;;^UTILITY(U,$J,358.3,23935,0)
 ;;=491.20^^130^1451^14
 ;;^UTILITY(U,$J,358.3,23935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23935,1,3,0)
 ;;=3^Ob Ch Bronchitis W/O Exacerb
 ;;^UTILITY(U,$J,358.3,23935,1,4,0)
 ;;=4^491.20
 ;;^UTILITY(U,$J,358.3,23935,2)
 ;;=^269953
 ;;^UTILITY(U,$J,358.3,23936,0)
 ;;=492.8^^130^1451^10
 ;;^UTILITY(U,$J,358.3,23936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23936,1,3,0)
 ;;=3^Emphysema Nec
 ;;^UTILITY(U,$J,358.3,23936,1,4,0)
 ;;=4^492.8
 ;;^UTILITY(U,$J,358.3,23936,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,23937,0)
 ;;=V17.3^^130^1451^12
 ;;^UTILITY(U,$J,358.3,23937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23937,1,3,0)
 ;;=3^Fam Hx-Ischem Heart Dis
 ;;^UTILITY(U,$J,358.3,23937,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,23937,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,23938,0)
 ;;=410.92^^130^1451^1
 ;;^UTILITY(U,$J,358.3,23938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23938,1,3,0)
 ;;=3^AMI NOS, Subsequent
 ;;^UTILITY(U,$J,358.3,23938,1,4,0)
 ;;=4^410.92
 ;;^UTILITY(U,$J,358.3,23938,2)
 ;;=^269675
 ;;^UTILITY(U,$J,358.3,23939,0)
 ;;=412.^^130^1451^15
 ;;^UTILITY(U,$J,358.3,23939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23939,1,3,0)
 ;;=3^Old Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,23939,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,23939,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,23940,0)
 ;;=V45.01^^130^1451^4
 ;;^UTILITY(U,$J,358.3,23940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23940,1,3,0)
 ;;=3^Cardiac Pacemaker In Situ
 ;;^UTILITY(U,$J,358.3,23940,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,23940,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,23941,0)
 ;;=519.9^^130^1451^18
 ;;^UTILITY(U,$J,358.3,23941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23941,1,3,0)
 ;;=3^Resp System Disease Nos
 ;;^UTILITY(U,$J,358.3,23941,1,4,0)
 ;;=4^519.9
 ;;^UTILITY(U,$J,358.3,23941,2)
 ;;=^105137
 ;;^UTILITY(U,$J,358.3,23942,0)
 ;;=V17.49^^130^1451^11
 ;;^UTILITY(U,$J,358.3,23942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23942,1,3,0)
 ;;=3^Fam Hx-Cardiovas Dis Nec
 ;;^UTILITY(U,$J,358.3,23942,1,4,0)
 ;;=4^V17.49
 ;;^UTILITY(U,$J,358.3,23942,2)
 ;;=^295306
 ;;^UTILITY(U,$J,358.3,23943,0)
 ;;=V45.82^^130^1451^16
 ;;^UTILITY(U,$J,358.3,23943,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1CP
